Vaccine Design and Testing – News and Features

A vaccine under development at the University at Buffalo has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu.

Researchers have developed STITCHR, a new gene editing tool that can insert therapeutic genes into specific locations without causing unwanted mutations. The system can be formulated completely as RNA, dramatically simplifying delivery logistics.

Researchers have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine, which has shown promise in animal models.

Contamination is one of the main roadblocks to successful cell culture. This article explores the different types of contamination, how to identify microbial contaminants in cell culture and best practices for removal and prevention.

After decades of trial and error, a promising new target for Lyme disease is emerging, the lyme bacterial protein CspZ, which the bacteria use to evade detection from the body’s immune system.

New research from The University of Texas at Austin could aid in improving whooping cough vaccines to once again push this disease toward eradication by targeting two key weaknesses in the infection.

MIT researchers have developed a way to rapidly manufacture specialized nanoparticles that can be used for targeted delivery of cancer drugs and other therapeutics.

Researchers have uncovered a key cellular mechanism that affects the function of mRNA vaccines and therapeutics, which could pave the way for more effective RNA-based therapies.

Researchers analyzing the health records of Welsh older adults discovered that those who received the shingles vaccine were 20% less likely to develop dementia over the next seven years than those who did not receive the vaccine.

In this interview, Technology Networks talked to Dr. Stacy Lindborg, president, chief executive officer and board member at IMUNON, Inc., who shares how its PlaCCine® platform could reshape vaccine development.